Hamish Ryder

1.5k total citations
46 papers, 1.2k citations indexed

About

Hamish Ryder is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Hamish Ryder has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Hamish Ryder's work include Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), Neuropeptides and Animal Physiology (7 papers) and Phosphodiesterase function and regulation (7 papers). Hamish Ryder is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), Neuropeptides and Animal Physiology (7 papers) and Phosphodiesterase function and regulation (7 papers). Hamish Ryder collaborates with scholars based in Spain, United Kingdom and Switzerland. Hamish Ryder's co-authors include Jörge Beleta, Vı́ctor Segarra, Montserrat Miralpeix, José Palacios, Ian Shaw, Paul Bevan, Peter Charlton, Michael Szelke, Teresa Domènech and Amadeu Gavaldà and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hamish Ryder

45 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hamish Ryder

Since Specialization

Citations

This map shows the geographic impact of Hamish Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamish Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamish Ryder more than expected).

Fields of papers citing papers by Hamish Ryder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamish Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamish Ryder. The network helps show where Hamish Ryder may publish in the future.

Co-authorship network of co-authors of Hamish Ryder

This figure shows the co-authorship network connecting the top 25 collaborators of Hamish Ryder. A scholar is included among the top collaborators of Hamish Ryder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamish Ryder. Hamish Ryder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Characterization of Abediterol, a Novel Inhaled β2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Mònica Aparici, Mireia Gómez-Angelats, Dolors Vilella, (unknown), (unknown), Marisa Viñals, Israel Ramos, Amadeu Gavaldà, Jorge De Alba, (unknown), Julio Cortijo, Esteban Morcillo, (unknown), Hamish Ryder, Jörge Beleta, Montserrat Miralpeix	44
2	Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors 2011 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Amadeu Gavaldà, (unknown), Elena Calama, J.L. Montero, (unknown), Montserrat Miralpeix, Dolors Vilella, (unknown), Jörge Beleta, Hamish Ryder, Lluı́s Pagès	14
3	Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, (unknown), Cristina Carreño, Marisa Viñals, Teresa Domènech, (unknown), (unknown), Dolors Vilella, (unknown), Julio Cortijo, Esteban Morcillo, Jesús Llenas, Hamish Ryder, Jörge Beleta	108
4	New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arsenio Nueda, José Luis Dı́az, Jörge Beleta, Á. de Pablo Cárdenas, (unknown), Marı́a Isabel Cadavid, Marı́a Isabel Loza, Hamish Ryder, Bernat Vidal	20
5	Synthesis and structure–activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Sı́lvia Fonquerna, M. Miralpeix, Lluı́s Pagès, (unknown), (unknown), (unknown), Dolors Vilella, Mònica Aparici, José Saborit, Graham J. Warrellow, Jörge Beleta, Hamish Ryder	12
6	Combinatorial approaches towards the discovery of new tryptase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Dolors Fernández‐Forner, Montserrat Miralpeix, Vı́ctor Segarra, Hamish Ryder, Míriam Royo, Fernando Alberício	11
7	Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance 2002 ·Bioorganic & Medicinal Chemistry Letters ·Shouming Wang, Hamish Ryder, (unknown), Paul Depledge, John Milton, Timothy C. Hancox, Ian L. Dale, Wendy Dangerfield, Peter Charlton, Richard Faint, (unknown), (unknown)	32
8	Synthesis and Evaluation of Some Pyrazolo[3,4-d]pyridazinones and Analogues as PDE 5 Inhibitors Potentially Useful as Peripheral Vasodilator Agents 2002 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Vittorio Dal Piaz, (unknown), Claudia Vergelli, Maria Paola Giovannoni, Amadeu Gavaldà, Vı́ctor Segarra, Jörge Beleta, Hamish Ryder, José María Fernández Palacios	22
9	Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties 2000 ·Bioorganic & Medicinal Chemistry Letters ·M. Crespo, (unknown), (unknown), Armando Vega, Josep Bou, Jordi Beleta, Teresa Domènech, Hamish Ryder, Vı́ctor Segarra, José Palacios	29
10	In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance 1999 ·British Journal of Cancer ·Prakash Mistry, Jane A. Plumb, Sue Eccles, Sue‐Ann Watson, (unknown), Hamish Ryder, G. Box, Peter Charlton, David J. Templeton, (unknown)	17
11	Computer-Assisted Comparison of the Structural and Electronic Dispositions of Ebastine and Terfenadine 1999 ·Drug Safety ·Vı́ctor Segarra, (unknown), Hamish Ryder, (unknown), David Roberts	7
12	XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase 1999 ·European Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), Hamish Ryder, Michael J. Moore, R. Charles Coombes	5
13	Prostaglandin E2 Inhibits SEB–Mediated Induction of the Cutaneous Lymphocyte–Associated Antigen 1999 ·International Archives of Allergy and Immunology ·Luis F. Santamaria‐Babí, Rosa Torres, Hamish Ryder, Jörge Beleta, José Palacios	4
14	Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives 1999 ·Bioorganic & Medicinal Chemistry Letters ·Michael W. Roe, Adrian Folkes, Philip J. Ashworth, (unknown), (unknown), (unknown), (unknown), Wendy Dangerfield, Hamish Ryder, Peter Charlton	135
15	Synthesis and biological evaluation of a conformationally free seco-analogue of the immunosuppressant FR901483 1999 ·Bioorganic & Medicinal Chemistry ·Josep Bonjoch, Fai͏̈za Diaba, (unknown), Daniel Solé, Vı́ctor Segarra, Luis F. Santamaria‐Babí, Jörge Beleta, Hamish Ryder, José Palacios	14
16	Rolipram Inhibits Staphylococcal Enterotoxin B-Mediated Induction of the Human Skin-Homing Receptor on T Lymphocytes 1999 ·Journal of Investigative Dermatology ·Luis F. Santamaria‐Babí, Rosa Torres, Hamish Ryder, José Palacios, Jörge Beleta, Ana M. Giménez‐Arnau, (unknown)	9
17	Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative 1998 ·British Journal of Cancer ·(unknown), (unknown), Richard Callaghan, J. A. Holmes, Karen H. Martin, M Luscombe, Prakash Mistry, Hamish Ryder, Alistair Stewart, Peter Charlton, PR Twentyman, (unknown)	43
18	Identifying small-molecule lead compounds: The screening approach to drug discovery 1995 ·Trends in biotechnology ·Paul Bevan, Hamish Ryder, Ian Shaw	67
19	Thrombin Inhibitors Based on Ketone Derivatives of Arginine and Lysine 1995 ·Journal of enzyme inhibition ·D. Michael Jones, Butrus Atrash, Hamish Ryder, Ann‐Catrine Teger‐Nilsson, (unknown), Michael Szelke	10
20	Inhibition of gastrin‐ and histamine‐stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat 1991 ·Alimentary Pharmacology & Therapeutics ·Barry H. Hirst, Kathryn Elliott, Hamish Ryder, Michael Szelke	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact